Jul 29, 2019 | Featured, Research News, Technology Updates
FDA OKs First-Ever Nasal Glucagon for Severe Hypos in Diabetes, as reported by Miriam E. Tucker for Medscape.com, 25 July 2019. The US Food and Drug Administration (FDA) has approved the first nasally administered glucagon product (Baqsimi, Eli Lilly and Co) for the...